145 related articles for article (PubMed ID: 36576122)
41. Synthesis and selective inhibitory effects of some 2-oxindole benzenesulfonamide conjugates on human carbonic anhydrase isoforms CA I, CA II, CA IX and CAXII.
George RF; Said MF; Bua S; Supuran CT
Bioorg Chem; 2020 Jan; 95():103514. PubMed ID: 31887473
[TBL] [Abstract][Full Text] [Related]
42. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
[TBL] [Abstract][Full Text] [Related]
43. Tail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV and IX inhibitors.
Kumar A; Siwach K; Rom T; Kumar R; Angeli A; Kumar Paul A; Supuran CT; Sharma PK
Bioorg Chem; 2022 Jun; 123():105764. PubMed ID: 35366582
[TBL] [Abstract][Full Text] [Related]
44. Carbonic anhydrase and acetylcholinesterase inhibitory effects of carbamates and sulfamoylcarbamates.
Göçer H; Akincioğlu A; Göksu S; Gülçin İ; Supuran CT
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):316-20. PubMed ID: 24964347
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides.
Wilkinson BL; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2008 Mar; 51(6):1945-53. PubMed ID: 18307288
[TBL] [Abstract][Full Text] [Related]
46. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
Sethi KK; Verma SM; Tanç M; Purper G; Calafato G; Carta F; Supuran CT
Bioorg Med Chem; 2014 Mar; 22(5):1586-95. PubMed ID: 24513184
[TBL] [Abstract][Full Text] [Related]
47. Design and synthesis of benzenesulfonamide-linked imidazo[2,1-b][1,3,4]thiadiazole derivatives as carbonic anhydrase I and II inhibitors.
Swain B; Aashritha K; Singh P; Angeli A; Kothari A; Sigalapalli DK; Yaddanapudi VM; Supuran CT; Arifuddin M
Arch Pharm (Weinheim); 2021 Jul; 354(7):e2100028. PubMed ID: 33760299
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and Characterization of Novel 1,3-Diaryltriazene-Substituted Sulfaguanidine Derivatives as Selective Carbonic Anhydrase Inhibitors: Biological Evaluation, in Silico ADME/T and Molecular Docking Study.
Akocak S; Lolak N; Duran HE; Işık M; Türkeş C; Durgun M; Beydemir Ş
Chem Biodivers; 2023 Aug; 20(8):e202300611. PubMed ID: 37470688
[TBL] [Abstract][Full Text] [Related]
49. Iodoquinazolinones bearing benzenesulfonamide as human carbonic anhydrase I, II, IX and XII inhibitors: Synthesis, biological evaluation and radiosensitizing activity.
Soliman AM; Ghorab MM; Bua S; Supuran CT
Eur J Med Chem; 2020 Aug; 200():112449. PubMed ID: 32485534
[TBL] [Abstract][Full Text] [Related]
50. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
[TBL] [Abstract][Full Text] [Related]
51. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
[TBL] [Abstract][Full Text] [Related]
52. Synthesis of novel acyl selenoureido benzensulfonamides as carbonic anhydrase I, II, VII and IX inhibitors.
Angeli A; Carta F; Bartolucci G; Supuran CT
Bioorg Med Chem; 2017 Jul; 25(13):3567-3573. PubMed ID: 28522267
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of N-heteroarylsubstituted triazolosulfonamides as carbonic anhydrase inhibitors.
Balci A; Arslan M; Nixha AR; Bilen C; Ergun A; Gençer N
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):377-82. PubMed ID: 25068730
[TBL] [Abstract][Full Text] [Related]
54. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
Ghorab MM; Soliman AM; Bua S; Supuran CT
Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
[TBL] [Abstract][Full Text] [Related]
55. Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII.
Ibrahim DA; Lasheen DS; Zaky MY; Ibrahim AW; Vullo D; Ceruso M; Supuran CT; Abou El Ella DA
Bioorg Med Chem; 2015 Aug; 23(15):4989-4999. PubMed ID: 26048024
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of isoxazole-containing sulfonamides with potent carbonic anhydrase II and VII inhibitory properties.
Altug C; Güneş H; Nocentini A; Monti SM; Buonanno M; Supuran CT
Bioorg Med Chem; 2017 Feb; 25(4):1456-1464. PubMed ID: 28111158
[TBL] [Abstract][Full Text] [Related]
57. Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.
Karalı N; Akdemir A; Göktaş F; Eraslan Elma P; Angeli A; Kızılırmak M; Supuran CT
Bioorg Med Chem; 2017 Jul; 25(14):3714-3718. PubMed ID: 28545816
[TBL] [Abstract][Full Text] [Related]
58. Carbonic anhydrase inhibitors: Design, synthesis and structural characterization of new heteroaryl-N-carbonylbenzenesulfonamides targeting druggable human carbonic anhydrase isoforms.
Buemi MR; De Luca L; Ferro S; Bruno E; Ceruso M; Supuran CT; Pospíšilová K; Brynda J; Řezáčová P; Gitto R
Eur J Med Chem; 2015 Sep; 102():223-32. PubMed ID: 26276436
[TBL] [Abstract][Full Text] [Related]
59. Synthesis of sulfonamides incorporating piperazinyl-ureido moieties and their carbonic anhydrase I, II, IX and XII inhibitory activity.
Congiu C; Onnis V; Deplano A; Balboni G; Dedeoglu N; Supuran CT
Bioorg Med Chem Lett; 2015 Sep; 25(18):3850-3. PubMed ID: 26233435
[TBL] [Abstract][Full Text] [Related]
60. Anticancer effects of new dibenzenesulfonamides by inducing apoptosis and autophagy pathways and their carbonic anhydrase inhibitory effects on hCA I, hCA II, hCA IX, hCA XII isoenzymes.
Gul HI; Yamali C; Bulbuller M; Kirmizibayrak PB; Gul M; Angeli A; Bua S; Supuran CT
Bioorg Chem; 2018 Aug; 78():290-297. PubMed ID: 29621641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
